Digital transformation is critical to the future of the biopharmaceutical industry, but how successful have we been at creating effective “data cultures”?

​The 2022 Data & Analytics in Biopharmaceuticals survey, conducted by the Data & Analytics team at ClinicalMind, was designed to help answer that question. We surveyed leaders and executives in Life Science to assess the perceptions, challenges, and drivers related to this exciting era of digital transformation.